Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

Thailand receives its first coronavirus vaccines

Published 02/24/2021, 12:16 AM
Updated 02/24/2021, 12:21 AM
© Reuters. Arrival of a shipment of 200,000 doses of the Sinovac coronavirus disease (COVID-19) vaccine at Bangkok's Suvarnabhumi International Airport

BANGKOK (Reuters) - Thailand received on Wednesday its first 200,000 doses of Sinovac Biotech's CoronaVac, the country's first batch of coronavirus vaccines, with inoculations set to begin in a few days.

Prime Minister Prayuth Chan-ocha is expected to be among the first to receive the vaccine this weekend. Most doses have been reserved for frontline medical workers.

"Thank you to the People's Republic of China for delivering the vaccine this month and subsequent months," Prayuth said on the tarmac at Bangkok's Suvarnabhumi Airport, where a refrigerated container bearing the flags of the two countries was lowered from a Thai Airways plane.

Health Minister Anutin Charnvirakul earlier this week said 117,000 doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine would also arrive on Wednesday and that Prayuth would be among the first recipients.

Thailand is expecting to take delivery of a further 1.8 doses of CoronaVac in March and April, to be given mainly to health workers and at-risk groups.

The country has so far been spared of the kind of epidemic seen elsewhere, with just over 25,000 infections overall.

The vaccine's arrival comes amid some public criticism of the government and accusations it has been too slow to secure the vaccines.

Its mass immunization campaign, which aims to administer 10 million doses a month, is slated to begin in June, using 26 million shots of AstraZeneca vaccines produced by local firm Siam Bioscience. It has also reserved a further 35 million doses of the vaccine.

The government has said it plans to vaccinate more than half the adult population this year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We will procure more as we produce them so there is enough to create herd immunity in our country," Prayuth said.

He said the Chinese vaccine would need a few days to be prepared for inoculations.

"As for who will take it first is another story," he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.